1.Scholthof, KB (2007) The disease triangle: pathogens, the environment and society. Nature Reviews Microbiology 5(2), 152–156.
2.Woolhouse, M (2011) How to make predictions about future infectious disease risks. Philosophical Transactions of the Royal Society B 366, 2045–2054.
4.Wong, ZS, et al. (2017) A systematic review of early modeling studies of Ebola virus disease in West Africa. Epidemiology & Infection 145(6), 1069–1094.
5.WHO Ebola Response Team (2014) Ebola virus disease in West Africa – the first 9 months of the epidemic and forward projections. The New England Journal of Medicine 371(16), 1481–1495.
7.Chowell, D et al. (2015) Modeling the effect of early detection of Ebola. The Lancet Infectious Diseases 15, 148–149.
8.Lee-Kwan, SH et al. (2017) Facilitators and barriers to community acceptance of safe, dignified medical burials in the context of an Ebola epidemic, Sierra Leone, 2014. Journal of Health Communications 22(Suppl. 1), 24–30.
10.Out, A et al. (2017) An account of the Ebola virus disease outbreak in Nigeria: implications and lessons learnt. BMC Public Health 18, 3.
11.Lamb, LE et al. (2017) Formulating and improving care while mitigating risk in a military Ebola virus disease treatment unit. Journal of the Royal Army Medical Corps 163(1), 2–6.
12.Logue, CH et al. (2017) Case study: design and implementation of training for scientists deploying to Ebola diagnostic field laboratories in Sierra Leone: October 2014 to February 2016. Philosophical Transactions of the Royal Society B 372, 20160299.
15.Meltzer, M et al. (2014) Estimating the future number of cases in the Ebola epidemic — Liberia and Sierra Leone, 2014–2015. Morbidity and Mortality Weekly Report Supplement 63(3), 1–14.
16.Fraser, C (2007) Estimating individual and household reproduction numbers in an emerging epidemic. PLoS ONE 8, e758.
17.Tambo, E (2014) Non-conventional humanitarian interventions on Ebola outbreak crisis in West Africa: health, ethics and legal implications. Infectious Diseases of Poverty 3, 42. http://www.idpjournal.com/content/3/1/42.
19.Nyarko, Y et al. (2015) Preparing for Ebola virus disease in West African countries not yet affected: perspectives from Ghanian health professionals. Globalization and Health 11, 7.
25.Poletto, C et al. (2014) Assessing the impact of travel restrictions on international spread of the 2014 West African Ebola epidemic. Euro Surveillance 19(42), 20936.
26.Otsuki, S and Nishiura, H (2016) Reduced risk of importing Ebola virus disease because of travel restrictions in 2014: a retrospective epidemiological modeling study. PLoS ONE 11(9), e0163418.
27.Boguch, II et al. (2015) Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak. The Lancet 385(9962), 29–35.
28.Backer, JA and Wallinga, J (2016) Spatiotemporal analysis of the 2014 Ebola epidemic in West Africa. PLoS Computational Biology 12(12), e1005210.
29.Shoman, H, Karafillakis, E and Rawaf, S (2017) The link between the West African Ebola outbreak and health systems in Guinea, Liberia and Sierra Leone: a systematic review. Globalization and Health 13, 1.
31.Sharareh, NS, Sayama, H and MacDonald, R (2016) The Ebola crisis and the corresponding public behavior: a systems LOS dynamics approach. PLoS Currents Outbreaks. Edition 1. doi: 10.1371/currents.outbreaks.23badd9821870a002fa86bef6893c01d.
32.Fang, l-Q et al. (2016) Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone. Proceedings of the National Academy of Sciences of the United States of America 113(16), 4488–4493.
33.Dembek, ZF et al. (2017) Operational perspective of lessons learned from the Ebola crisis. Military Medicine 182(1), e1507–e1513.
34.Rivers, CM et al. (2014) Modeling the impact of interventions on an epidemic of Ebola in Sierra Leone and Liberia. PLoS Currents 6. doi: 10.1371/currents.outbreaks.4d41fe5d6c05e9df30ddce33c66d084c.
35.Earn, DJD et al. (2000) A simple model for complex dynamical transitions in epidemics. Science 287(5453), 667–670.
37.Merler, S et al. (2015) Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational modelling analysis. The Lancet Infectious Diseases 15(2), 204–211.
38.Chowell, G et al. (2017) Perspectives on model forecasts of the 2014-2015 Ebola epidemic in West Africa: lessons and the way forward. BMC Medicine 15(1), 42.
39.Heesterbeek, H et al. (2015) Modeling infectious disease dynamics in the complex landscape of global health. Science 347(6227), aaa4339.
40.Cohen, NJ et al. (2016) Travel and border health measures to prevent the international spread of Ebola. Morbidity and Mortality Weekly Review Supplement 65(3), 57–67.
41.Mutua, JM, Wang, F-B and Vaidya, NK (2015) Modeling malaria and typhoid fever co-infection dynamics. Mathematical Biosciences 264, 128–144.
42.Carias, C et al. (2016) Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of west Africa 2014–15 Ebola virus disease response: an economic analysis. The Lancet Infectious Diseases 16, 449–458.
43.Kilbourne, ED (1973) An explanation of the interpandemic antigenic mutability of influenza viruses. The Journal of Infectious Diseases 128(5), 668–670.
44.Smith, AM and McCullers, JA (2014) Secondary bacterial infections in influenza virus infection pathogenesis. Current Topics in Microbiology and Immunology 385, 327–356.
45.Cauley, LS and Vella, AT (2015) Why is co-infection with influenza virus and bacteria so difficult to control? Discovery Medicine 19(102), 33–40.
46.Smith, AM, et al. (2013) Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae. PLoS Pathogens 9(3), e1003238.
47.Kilbourne, ED and Loge, JP (1950) Influenza A prime: a clinical study of an epidemic caused by a new strain of virus. Annals of Internal Medicine 33, 371–379.
48.Baguelin, M et al. (2013) Assessing optimal target populations for influenza vaccine programs: an evidence synthesis and modeling study. PLoS Medicine 10(10), e1001527.
49.Mateus, ALP et al. (2014) Effectiveness of travel restrictions in the rapid containment of human influenza: a systemic review. Bulletin of the World Health Organization 92(12), 868–880D.
50.Takeuchi, J and Yamanishi, K (2006) A unifying framework for detecting outliers and change points from time series. IEEE Transactions on Knowledge and Data Engineering 18(4), 482–492.
51.Sharpe, JD et al. (2016) Evaluating Google, Twitter, and Wikipedia as tools for influenza surveillance using Bayesian change point analysis: a comparative analysis. JMIR Public Health and Surveillance 2(2), e161.
52.Boianelli, A et al. (2015) Modeling influenza virus infection: a roadmap for influenza research. Viruses 7, 5274–5304.
55.Mizumoto, K et al. (2013) Vaccination and clinical severity: is the effectiveness of contact tracing and case isolation hampered by past vaccination? International Journal of Environmental Research and Public Health 10, 816–829.
56.Eichner, M and Dietz, K (2003) Transmission potential of smallpox: estimates based on detailed data from an outbreak. American Journal of Epidemiology 158(2), 110–117.
57.Stockdale, JE, Kypraios, T and O'Neill, PD (2017) Modeling and Bayesian analysis of the Abakaliki smallpox outbreak. Epidemics 19, 13–23.
58.Henderson, RH and Yekpe, M (1969) Smallpox transmission in Southern Dahomey. A study of a village outbreak. American Journal of Epidemiology 90(5), 423–428.
59.Meltzer, M et al. (2001) Modelling potential responses to smallpox as a bioterrorist weapon. Emerging Infectious Diseases 7(6), 959–969.
61.Legrand, J et al. (2009) Estimating the location and spatial extent of a covert anthrax release. PLoS Computational Biology 5(1), e1000356.
62.Rainisch, G et al. (2017) Modeling tool for decision support during early days of an anthrax event. Emerging Infectious Diseases 23(1), 46–55.
63.Hupert, N et al. (2009) Predicting hospital surge after a large-scale anthrax attack: a model-based analysis of CDC's cities readiness initiative prophylaxis recommendations. Medical Decision Making 29(4), 424–437.
67.Chao, DL, Longini, IM and Morris, JG (2014) Modeling cholera outbreaks. Current Topics in Microbial Immunology 379, 195–209.
68.Grad, YH, Miller, JC and Lipsitch, M (2012) Cholera modeling: challenges to quantitative analysis and predicting the impact of interventions. Epidemiology 23(4), 523–530.
69.Kirpich, A et al. (2015) Cholera transmission in Ouest department of Haiti: dynamic modeling and the future of the epidemic. PLoS Neglected Tropical Diseases 9(10), e0004153.
70.Chao, DL, Halloran, ME and Longini, IM (2011) Vaccination strategies for epidemic cholera in Haiti with implications for the developing world. Proceedings of the National Academy of Sciences of the United States of America 108(17), 7081–7085.
72.Fung, IC-H et al. (2013) Modeling the effect of water, sanitation, and hygiene and oral cholera vaccine implementation in Haiti. American Journal of Tropical Medicine 89(4), 633–640.
73.Mogasale, V et al. (2016) Oral cholera vaccine delivery cost in mow- and middle-income countries: an analysis based on systematic review. PLoS Neglected Tropical Diseases 10(12), e0005124.
74.Jackson, SS and Chen, WH (2015) Evidence for CVD 103-HgR as an effective single-dose oral cholera vaccine. Future Microbiology 10(8), 1271–1281.
76.Chen, WH et al. (2016) Single-dose live oral cholera vaccine CVD 103-HgR protects against human experimental infection with Vibrio cholerae O1 El Tor. Clinical Infectious Diseases 62(11), 1329–1335.
77.Levine, MM et al. (2017) Paxvax CVD 103-HgR single-dose live oral cholera vaccine. Expert Review of Vaccines 16(3), 197–213.
79.Schaetti, C, et al. (2012) Costs of illness due to cholera, costs of immunization and cost-effectiveness of mass vaccination campaign in Zanzibar. PLoS Neglected Tropical Diseases 6(10), e1844.
80.Reyburn, R et al. (2011) The case for reactive mass oral cholera vaccinations. PLoS Neglected Tropical Diseases 5(1), e952.
81.Azman, AS and Lesser, J (2015) Reactive vaccination in the presence of disease hotspots. Proceedings of the Royal Society B 282, 20141341.
82.Hutubessy, R et al. (2011) Results from evaluation of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal. BMC Medicine 9, 55.
83.Jeuland, M et al. (2009) A cost-benefit analysis of cholera vaccination programs in Beira, Mozambique. The World Bank Economic Review 23(2), 235–267.
84.Wang, J and Liao, S (2012) A generalized cholera model and epidemic-endemic analysis. Journal of Biological Dynamics 6(2), 568–589.
86.Pitzer, VE et al. (2015) Mathematical modeling to assess the drivers of the recent emergence of typhoid fever in Blantyre, Malawi. Clinical Infectious Diseases 61 (Suppl. 4), S251–S258.
87.Steele, ADD et al. (2016) Challenges and opportunities for typhoid fever control: a call for coordinated action. Clinical Infectious Diseases 62(Suppl. 1), S4–S8.
88.Karkey, A, et al. (2010) The burden and characteristics of enteric fever at a healthcare facility in a densely populated area of Kathmandu. PLoS ONE 5(11), e13988.
89.Crump, JA and Mintz, ED (2010) Global trends in typhoid and paratyphoid fever. Clinical Infectious Diseases 50(2), 241–246.
90.Dietz, K and Heesterbeek, JAP (2002) Daniel Bernoulli's epidemiological model revisited. Mathematical Biosciences 180, 1–21.
91.Lipp, EK, Hug, A and Colwell, RR (2002) Effects of global climate on infectious disease: the cholera model. Clinical Microbiology Reviews 15(4), 757–770.
92.Delgleize, E et al. (2016) Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model. BMJ Open 6, e010776.
93.Lukuge, K et al. (2016) Successful control of Ebola virus disease: analysis of service based data from rural Sierra Leone. PLoS Neglected Tropical Diseases 10(3), e0004498.
96.Tatem, AJ, Rogers, DJ and Hay, SI (2006) Global transport networks and infectious disease spread. Advances in Parasitology 62, 293–343.
97.Hay, SI et al. (2013) Global mapping of infectious disease. Philosophical Transactions of the Royal Society B 368(1614), 2012050.
98.Cooper, PJ et al. (2001) Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera B vaccine CVD 103-HgR. Infection and Immunity 69(3), 1574–1580.
99.Yang, T et al. (2018) High prevalence of syphilis, HBV, and HCV co-infection, and low rate of effective vaccination against hepatitis B in HIV-infected patients in West China hospital. Journal of Medical Virology 90, 101–108.
100.Biraro, IA et al. (2014) Impact of co-infections and BCG immunisation on immune responses among household contacts of tuberculosis patients in an Ugandan cohort. PLoS ONE 9(11), e111517.
101.Kracalik, IT et al. (2017) Modeling the environmental suitability of anthrax in Ghana and estimating populations at risk: implications for vaccination and control. PLoS Neglected Tropical Diseases 11(10), e0005885.
102.Hamilton, MA, et al. (2017) Risk-based decision making for reoccupation of contaminated areas following a wide-area anthrax release. Risk Analysis. 35(7), 1348–1363.
103.Chen, W-J et al. (2016) Mapping the distribution of anthrax in mainland China, 2005-2013. PLoS Neglected Diseases 10(4), e0004637.
104.Vergnaud, G et al. (2016) Comparison of French and worldwide Bacillus anthracis strains favors a recent, post-Columbian origin of the predominant North-American clade. PLoS ONE 11(2), e0146216.
105.Goff, DA et al. (2017) A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail. Lancet Infectious Diseases 17, e56–e63.
106.Editorial (2004) The catastrophic failures of public health. Lancet 363, 745.
107.Ngcamphalala, C and Ataguba, JE (2018) An assessment of financial catastrophe and impoverishment from out-of-pocket health care payments in Swaziland. Global Health Action 11, 1428473.
108.Christley, RM et al. (2013) “Wrong, but useful”: negotiating uncertainty in infectious disease modelling. PLoS ONE 8(10), e76277.
109.Moore, SM et al. (2012) Improvement of disease prediction and modeling through the use of meteorological ensembles: human plague in Uganda. PLoS ONE 7(9), e44431.
110.Brainard, J et al. (2016) Risk factors for transmission of Ebola of Marburg viral disease: a systematic review and meta-analysis. International Journal of Epidemiology 45(1), 102–116.
111.Chowell, G et al. (2016) Mathematical models to characterize early growth: a review. Physics for the Life Sciences 18, 66–97.
112.Blower, S and Go, M-H (2011) The importance of including dynamic social networks when modeling epidemics of airborne infections: does increasing complexity increase accuracy? BMC Medicine 9, 88.
113.Hoffman, B (2005) Simplified models of the relationship between health and disease. Theoretical Medicine and Bioethics 26, 355–377.
114.Myers, MF et al. (2000) Forecasting disease risk for increased epidemic preparedness in public health. Advances in Parasitology 47, 309–330.
115.Meselson, M, et al. (1994) The Sverdlovsk anthrax outbreak of 1979. Science 266(5188), 1202–1208.